Race for Every Child: MBI makes its mark at a very special event

MBI’s first participation in the Race for Every Child, hosted in Washington, D.C., by our partner Children’s National Hospital, was simply sensational…
Valuable connections – A project born from belonging

Fernando Goldsztein, tells how the idea for the project came about and what he expects from these connections. This month, the II Conexões de Valor will take place, this project that had its first edition…
Weathering the storm together

It was a night to celebrate: MBI founder Fernando Goldsztein had the honor of stepping on stage together with MBI partner and medulloblastoma survivor Daniel Scola
MATCHPOINT: Has medulloblastoma met its match?

Duane Mitchell, MD, PhD, co-director of the Preston A. Wells Jr. Center for Brain Tumor Therapy at the University of Florida, is leading the MATCHPOINT trial. The treatment uses adoptive cell therapy…
TRIALS APPROVED!

Drs. Duane Mitchell and Elias Sayour of the Cure Group 4 Consortium have received approval from the U.S. Food and Drug Administration (FDA) to test…
You are invited to the Race for Every Child — Race for Every Child

It’s a real race in Washington DC, but you can enter from anywhere in the world — accelerating efforts to raise funds for research and care for children…
A milestone for MBI

Scientists, academics, researchers, businesspeople and media personalities met last Wednesday (10/04) at the Brazilian embassy in Washington…
To save a life: Lessons for Launching a Health R&D Initiative

In February 2024, MBI was featured in eJewish Philanthropy, a news publication covering the world of Jewish philanthropy. The platform features daily discussions through original reporting…
In search of treatment for medulloblastoma

In March 2024, PUCRS Magazine published a beautiful interview given by alumnus Fernando Goldsztein, Founder of The Medulloblastoma Initiative and Advisor to the Children’s National Hospital Foundation…
United Voices at the International Symposium on Pediatric Neuro-Oncology

United voices at the International Symposium on Pediatric Neuro-Oncology: “in many places around the world, medulloblastoma is still diagnosed as it was almost 100 years ago”…